Question: iPSC reprogramming efficiency optimization protocols

[replication] Since the two founding 2010 papers, has any study repeated retroviral or lentiviral OSKM reprogramming of bulk (non-enriched) human PBMCs and scored the result with an immunostain (AP, TRA-1-60, or NANOG) rather than colony morphology alone?